News
Patients prefer higher dose of levothyroxine despite lack of objective benefit
- Author:
- Susan London
VICTORIA, B.C. – Can you say placebo effect?
News
Long-term methimazole therapy improves Graves disease remission rate
- Author:
- Susan London
Keep methimazole on board to prevent Graves’ relapse after remission.
News
Add-on mycophenolate boosts efficacy of steroids for Graves’ orbitopathy
- Author:
- Susan London
Graves’ orbitopathy is more likely to respond to combination therapy than monotherapy,
News
Symptoms fail to predict benefit of hormone therapy in older adults with subclinical hypothyroidism
- Author:
- Susan London
Benefit may be overestimated because previous studies weren’t blinded.
News
Too few RA patients get timely adjustment of DMARDs
- Author:
- Susan London
The study is the first to examine time to DMARD therapy adjustment and time to low disease activity for RA patients with moderate to high disease...
Article
‘Making a difference in cancer care’
- Author:
- Susan London
- Kari Oakes
- and Sharon Worcester
News
Enasidenib data in IDH2-mutated AML are basis for combination therapy trials
- Author:
- Susan London
Enasidenib monotherapy was well tolerated and active in a phase 1/2 trial involving patients with relapsed or refractory IDH2-mutated AML.
News
Sequential pazopanib and everolimus nets good survival in metastatic RCC
- Author:
- Susan London
Sequential treatment with pazopanib and everolimus yields a median overall survival exceeding 2 years in predominantly older and sicker patients...
News
LIFSCREEN data support broader cancer screening in Li-Fraumeni syndrome
- Author:
- Susan London
Of 23 new primary cancers found through screening in 20 patients, 10 belonged to the core LFS spectrum of breast cancer, sarcoma, and brain tumors...
News
Immune signature shows good prognostic performance in early-stage NSCLC
- Author:
- Susan London
Patients in the signature-defined high-risk group had roughly twice the adjusted risk of death as that of those in the signature-defined low-risk...
News
Some adjuvant endocrine therapies better than others for young breast cancer patients
- Author:
- Susan London
Young women treated for early hormone receptor–positive, HER2-negative breast cancer fare better if their adjuvant endocrine therapy includes...
News
Low-fat diet reduces risk of death if breast cancer is diagnosed
- Author:
- Susan London
Death rates were lowered in women assigned to a low-fat diet after breast cancer diagnosis.
News
Plasma lipoprotein perturbations likely contribute to sickle cell vasculopathy
- Author:
- Susan London
Patients with sickle cell disease had reduced levels of HDL3 and altered functionality of HDL2, which were associated with an increased...
News
SUNSHINE: High-dose vitamin D boosts PFS in metastatic CRC
- Author:
- Susan London
CHICAGO – In a phase II trial, patients given FOLFOX chemotherapy and bevacizumab plus high-dose vitamin D had a one-third lower risk of...
News
Optimizing therapy in relapsed CLL: ibrutinib and beyond
- Author:
- Susan London
CHICAGO – The efficacy of ibrutinib is durable for patients with relapsed chronic lymphocytic leukemia (CLL), and combination strategies are...